Research map: Serum 1,5‐Anhydroglucitol Identifies Residual Mortality Risk Beyond Time in Range in Type 2 Diabetes: A Cohort Study

Back to the article

Papers in this map

  1. Activation of Oxidative Stress by Acute Glucose Fluctuations Compared With Sustained Chronic Hyperglycemia in Patients With Type 2 Diabetes · Louis Monnier · 2006 · 2481 citations · Cited by this paper
  2. Blood Pressure Status Modulates the Therapeutic Response to Sodium‐Glucose Cotransporter 2 Inhibitors in Diabetic Macular Edema: A Post Hoc Subgroup Analysis of the COMET Trial · 2025 · Related
  3. The Relationships Between Time in Range, Hyperglycemia Metrics, and HbA1c · Roy W. Beck · 2019 · 474 citations · Cited by this paper
  4. Beyond GLP ‐1 · 2026 · Related
  5. Complications of Diabetes and Metrics of Glycemic Management Derived From Continuous Glucose Monitoring · Michael Yapanis · 2022 · 297 citations · Cited by this paper
  6. November 11–12, 2025, T1DX‐QI Learning Session, Journal of Diabetes · 2026 · Related
  7. Optimal Sampling Duration for Continuous Glucose Monitoring to Determine Long-Term Glycemic Control · Tonya D. Riddlesworth · 2018 · 267 citations · Cited by this paper
  8. Multimorbidity between Type 2 Diabetes and Depressive Symptoms in Mexico: Prevalence and Associated Factors From the Nationally Representative ENSANUT 2022 Survey · 2026 · Related
  9. Time in Range Is Associated with Carotid Intima-Media Thickness in Type 2 Diabetes · Jingyi Lu · 2019 · 233 citations · Cited by this paper
  10. Effect of Topical Application of Antimicrobial Peptide PL ‐5 (Peceleganan) Spray on Mild to Moderate Infection of Diabetic Foot Ulcers: A Multicenter, Randomized, Double‐Blinded, Placebo‐Controlled Clinical Trial · 2026 · Related
  11. Serum 1,5-Anhydroglucitol (GlycoMark™): A Short-Term Glycemic Marker · John B. Buse · 2003 · 206 citations · Cited by this paper
  12. Efficacy and Safety of Glimepiride, Voglibose, and Metformin ER in Type 2 Diabetes: A Randomized, Active‐Controlled Study · 2026 · Related
  13. Hyperglycemic Stress and Carbon Stress in Diabetic Glucotoxicity · Xiaoting Luo · 2016 · 134 citations · Cited by this paper
  14. Delphi Consensus on the Use of Fenofibrate as Systemic Therapy for the Prevention of Diabetic Retinopathy Progression · 2026 · Related
  15. Effect of Daily Glucose Fluctuation on Coronary Plaque Vulnerability in Patients Pre-Treated With Lipid-Lowering Therapy · Masaru Kuroda · 2015 · 87 citations · Cited by this paper
  16. Diabetes and the Retina: The Role of Medical Treatment · 2025 · Related
  17. Visit‐to‐Visit Variability of Fasting Plasma Glucose and the Risk of Cardiovascular Disease and All‐Cause Mortality in the General Population · Anxin Wang · 2017 · 84 citations · Cited by this paper
  18. Mitochondrial Homeostasis in Pancreatic β Cell Function: Mechanisms and Therapeutic Targets for Diabetes · 2026 · Related
  19. Glucose variability and diabetes complications: Risk factor or biomarker? Can we disentangle the “Gordian Knot”? · Louis Monnier · 2021 · 57 citations · Cited by this paper
  20. IDF global clinical practice recommendations for managing type 2 diabetes – 2025 · Antonio Ceriello · 2025 · 55 citations · Cited by this paper
  21. Glycemic variability modifies the relationship between time in range and hemoglobin A1c estimated from continuous glucose monitoring: A preliminary study · Jingyi Lu · 2020 · 49 citations · Cited by this paper
  22. 1,5-Anhydroglucitol reflects postprandial hyperglycemia and a decreased insulinogenic index, even in subjects with prediabetes and well-controlled type 2 diabetes · Jong Chul Won · 2009 · 45 citations · Cited by this paper
  23. Glycemic variability: Measurement, target, impact on complications of diabetes and does it really matter? · Yifei Mo · 2023 · 43 citations · Cited by this paper
  24. Glucose Variability Assessed with Continuous Glucose Monitoring: Reliability, Reference Values, and Correlations with Established Glycemic Indices—The Maastricht Study · Yuri D. Foreman · 2019 · 42 citations · Cited by this paper
  25. Increased 1,5-Anhydroglucitol Predicts Glycemic Remission in Patients with Newly Diagnosed Type 2 Diabetes Treated with Short-Term Intensive Insulin Therapy · Liehua Liu · 2012 · 27 citations · Cited by this paper
  26. Association of glycemic variability assessed by continuous glucose monitoring with subclinical diabetic polyneuropathy in type 2 diabetes patients · Jiemin Pan · 2021 · 24 citations · Cited by this paper
  27. Comparison of glucose time in range and area under curve in range in relation to risk of diabetic retinopathy in type 2 diabetes patients · Yaxin Wang · 2022 · 22 citations · Cited by this paper
  28. Continuous glucose monitoring and microvascular complications in diabetes: Bridging glycemic metrics with clinical outcomes · Lilian Anagnostopoulou · 2025 · 17 citations · Cited by this paper
  29. Association of time in tight range and 1,5‐anhydroglucitol in type 2 diabetes · Hang Su · 2025 · 7 citations · Cited by this paper
  30. Clinically relevant stratification of patients with type 2 diabetes by using continuous glucose monitoring data · Xiaopeng Shao · 2024 · 5 citations · Cited by this paper
  31. Low serum 1,5‐anhydroglucitol is associated with increased risk of all‐cause and cardiovascular mortality in type 2 diabetes: A real‐world cohort study · Jiaying Ni · 2025 · 2 citations · Cited by this paper
  32. 1,5‐Anhydroglucitol and Time in Range as Complementary Markers for Diabetic Retinopathy in Type 2 Diabetes · Hang Su · 2026 · 2 citations · Cited by this paper
  33. Untitled · Cited by this paper

Source: OpenAlex (CC0)